A qualitative study of ovarian cancer survivors' perceptions of endpoints and goals of care

Understanding the Treatment Preferences of Seriously Ill Patients

Terri R. Fried, Elizabeth H. Bradley, Virginia Towle et al. · New England Journal of Medicine · 2002 · 1.5K citations · Full text

How Accurate Is Clinician Reporting of Chemotherapy Adverse Effects? A Comparison With Patient-Reported Symptoms From the Quality-of-Life Questionnaire C30

Erik K. Fromme, Kristine M. Eilers, Motomi Mori et al. · Journal of Clinical Oncology · 2004 · 553 citations

Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial

Noriyuki Katsumata, Makoto Yasuda, Seiji Isonishi et al. · The Lancet Oncology · 2013 · 468 citations

Gastrointestinal Oncology, Conventional Paclitaxel, Medicine +9

2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004)

Andreas du Bois, Michael Quinn, Tate Thigpen et al. · Annals of Oncology · 2005 · 465 citations

Medicine, Cancer Management, Reproductive Health +9

Social Support During the Postpartum Period: Mothers’ Views on Needs, Expectations, and Mobilization of Support

Rennie Negron, Anika Martin, Meital Almog et al. · Maternal and Child Health Journal · 2012 · 407 citations

Nursing, Respectful Maternity Care, Family Involvement +5